Clinical Audit: TAILOR - Target Antidepressant Initiation choice to unLock positive patient Outcomes and Response
- : Sydney Olympic Park NSW 2127
Clinical Audit | RACGP C1: 40pts | ACRRM: 30pts | GPs on]
For a diagnosis of depression, current guidelines (RACGP Red Book 20121 and DSM-52) identify depressed mood (negative affect), and/or diminished interest and pleasure (positive affect) as the key symptoms.Audit Aim
This clinical audit aims to tailor the choice of anti-depressant medication for a patient with depression to achieve more positive patient outcomes and response with a clear focus on involving the patient in all management decisions.Why take part in this audit?
The inclusion criteria for the TAILOR clinical audit are for patients to present with:
The audit has been designed to take approximately 8-10 weeks to complete. This includes patient recall from your practice, patient consult and audit evaluation.Steps to Proceed What the GP needs to do
- Log in or register on this page
- Use the 'Click here to proceed' button to get started.
- Read the background information and answer some questions.
- Please complete this 15 minute activity before your first audit patient.
Why not do it now?
- Based on a clinical assessment you are about to initiate an anti-depressant treatment (i.e. not currently on anti-depressant medication)
- Enter this information in the patient data entry section of the audit.
- Based on this information, discuss your choice of anti-depressant medication with the patient tailored to be the best fit for their case
- Once you have entered data for 10 patients, review your results and evaluate the audit process
- To gain CPD points you will be asked 4 weeks later to complete a follow up online questionnaire to evaluate how this audit has affected your practice
1. Guidelines for preventive activities in general practice, 8th edition. East Melbourne (Australia): Royal Australian College of General Practitioners; 2012.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders Fifth Edition. Arlington, VA. American Psychiatric Association; 2013.
This program has been developed with an educational grant from Servier Laboratories.